Longitudinal myelitis is an uncommon complication of systemic lupus erythematosus (SLE). We describe an unusual case of longitudinal myelitis and ischemic stroke in the presence of homozygous prothrombin G20210A, heterozygous MTHFR 677T mutations and the absence of antiphospholipid antibodies in a young woman with SLE. Lupus (2007) 16, 517—520.
Kovacs B., Lafferty LT, Brent HL, DeHoratius J.Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis2000; 59: 120—124.
2.
Mok CC, Lau CS, Chan EY, Wong RWAcute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome. J Rheumatol1998; 25: 467—473.
3.
Kaplin AI, Krishnan C., Deshpande DM, Pardo CA, Kerr DADiagnosis and management of acute myelopathies. Neurologist2005; 11: 2—18.
4.
Tellez-Zenteno JF, Remes-Troche JM, Negrete-Pulido RO, Davila-Maldonado L.Longitudinal myelitis associated with systemic lupus erythematosus: clinical features and magnetic resonance imaging of six cases. Lupus2001; 10: 851—856.
5.
Cuadrado MJ, Khamashta MA, Ballesteros A., Godfrey T., Simon MJ, Hughes Grv.Can Neurologic Manifestations of Hughes (Antiphospholipid) Syndrome Be Distinguished from Multiple Sclerosis?: Analysis of 27 Patients and Review of the Literature . Medicine2000; 79: 57—68.
6.
D'Cruz DP, Mellor-Pita S., Joven B. et al. Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. J Rheumatol2004; 31: 280—285.
7.
Toubi E., Khamashta MA, Panarra A., Hughes GRAssociation of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med1995; 99: 397—401.
8.
Poort SR, Rosendaal FR, Reitsma PH, Bertina RMA common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood1996; 88: 3698—3703.
9.
Nguyen A.Prthrombin G20210A polymorphism and thrombophilia. Mayo Clin Proc2000; 75: 595—604.
10.
Afeltra A., Vadacca M., Conti L. et al. Thrombosis in systemic lupus erythematosus: Congenital and acquired risk factors. Arthritis Care & Research2005; 53: 452—459.
11.
Brouwer JL, Bijl M., Veeger NJ, Kluin-Nelemans HC, van der Meer J.The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood2004; 104: 143—148.
12.
Girolami A. , Simioni P., Tormene D., Scarano L.Two additional homozygous patients for the 20210 prothrombin polymorphism with no venous thrombosis. Thrombosis Research1999; 96: 415—417.
13.
Cronin S., Furie KL, Kelly PJDose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis. Stroke2005; 3: 1581—1587.
14.
Wagner DDNew links between inflammation and thrombosis. Arterioscler Thromb Vasc Biol2005; 25: 1321—1324.
